Below you can find all of the shared care guidelines approved for use across the North East and North Cumbria ICS.

For legacy shared care guidelines, you may still need to visit the previous APC websites until a single NENC ICB version is available.

NTAG workplan includes the review of shared care clinical protocols across NENC ICS. Due to historical arrangements shared care clinical protocols differ geographically. Following review by NTAG, these new ICS wide approved clinical protocols are now being published to ensure clinical information is correct and up to date. NTAG is aware that there is an ongoing LIS/LES review (Local Incentive Scheme and Local Enhanced Service) within the ICB that is reviewing the remuneration to GP practices for undertaking shared care across the ICS.

The shared care guidelines includes a letter template for requesting shared care and letter templates to respond to the shared care request. Copies of these are also available at these links: Shared Care Request Letter and Shared Care Agreement Letter
(Note some NENC SCGs include extra clinical detail in the shared care letter templates that form part of that shared care guideline to aid in the safe transfer of shared care for that particular drug).

Title Documents Decision Date
NENC Shared Care Protocol - Amiodarone for patients in adult services NENC-SCP-amiodarone- v3.0 - approved March 2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/03/2026
NENC Shared Care Protocol - Apomorphine injection for patients within adult services with Parkinson's disease NENC SCG - apomorphine injection in parkinson - v1.1 - May 2025 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 12/12/2024
NENC Shared Care Protocol – Atomoxetine for patients within adult services NENC-SCG-Atomoxetine-for-patients-within-adult-services-v1.0-approved-Feb-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/02/2026
NENC Shared Care Protocol – Atomoxetine for patients within children’s services NENC-SCG-Atomoxetine-for-patients-within-childrens-services-v1.0-approved-Feb-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/02/2026
NENC Shared Care Protocol - Azathioprine and mercaptopurine within adult services (non-transplant indications) NENC-SCG-azathioprine-mercaptopurine-in-adults-for-non-transplant-indications-v1.0-approved-Dec-2024-review-date-extended Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 12/12/2024
NENC Shared Care Protocol - Ciclosporin (oral) for patients within adult services (non-transplant indications) NENC-SCP-Ciclosporin-oral-adults-non-transplant-indications-v1.1-approved-May-2025-review-date-extended Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 10/04/2025
NENC Shared Care Protocol - Cinacalcet for the management of complex primary hyperparathyroidism in adults NENC SCP - Cinacalcet for the management of complex primary hyperparathyroidism in adults - v1.0 approved Jan 2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 22/01/2026
NENC Shared Care Protocol - Dapsone for patients within adult services NENC SCP - Dapsone for patients within adult services - v1.0 approved Oct 2025 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 09/10/2025
NENC Shared Care Protocol - Denosumab for primary and secondary fracture prevention in adults NENC SCP - Denosumab for primary and secondary prevention of fracture in adults - v1.1 - June 2025 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 10/04/2025
NENC Shared Care Protocol – Dexamfetamine for patients within adult services NENC-SCG-Dexamfetamine-for-patients-within-adult-services-v1.0-approved-Feb-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/02/2026
NENC Shared Care Protocol – Dexamfetamine for patients within children’s services NENC-SCG-Dexamfetamine-for-patients-within-childrens-services-v1.0-approved-Feb-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/02/2026
NENC Shared Care Protocol - Dronedarone for patients in adult services NENC-SCP-dronedarone- v3.0 - approved March 2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/03/2026

Updated

06/07/2026
NENC Shared Care Protocol – Guanfacine for patients within adult services NENC-SCG-Guanfacine-for-patients-within-adult-services-v2.0-approved-May-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 04/06/2026

Updated

06/07/2026
NENC Shared Care Protocol – Guanfacine for patients within children’s services NENC-SCG-Guanfacine-for-patients-within-childrens-services-v2.0-approved-May-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 04/06/2026
NENC Shared Care Protocol - Hydroxychloroquine for patients within adult services NENC-SCP-hydroxychloroquine-v1.1-approved-Feb-2025-review-date-extended Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 13/02/2025
NENC Shared Care Protocol - Leflunomide for patients within adult services NENC-SCP-Leflunomide-for-patients-within-adult-services-v1.0-approved-Feb-2025-review-date-extended Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 13/02/2025
NENC Shared Care Protocol – Lisdexamfetamine for patients within adult services NENC-SCG-Lisdexamfetamine-for-patients-within-adult-services-v1.0-approved-Feb-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/02/2026
NENC Shared Care Protocol – Lisdexamfetamine for patients within children’s services NENC-SCG-Lisdexamfetamine-for-patients-within-childrens-services-v1.0-approve-Feb-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/02/2026

Updated

06/07/2026
NENC Shared Care Protocol - Lithium for adult patients NENC-SCP-lithium-in-adults - v2.0 - approved May 2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 04/06/2026
NENC Shared Care Protocol - Methotrexate (oral and subcutaneous) for patients in adult services (excluding cancer care) NENC-SCP-methotrexate-in-adults-excluding-cancer-care-v1.1 - approved July 2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 11/12/2025
NENC Shared Care Protocol – Methylphenidate for patients within adult services NENC-SCG-Methylphenidate-for-patients-within-adult-services-v1.0-approved-Feb-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/02/2026
NENC Shared Care Protocol – Methylphenidate for patients within children’s services NENC-SCG-Methylphenidate-for-patients-within-childrens-services-v1.1-approved-Feb-2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/02/2026
NENC Shared Care Protocol - Mycophenolate mofetil and mycophenolic acid in adults (non-transplant indications) NENC-SCP-mycophenolate-mofetil-mycophenolic-acid-in-adults-non-transplant-indications-v1.0-approved-Feb-2025-review-date-extended Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 13/02/2025
NENC Shared Care Protocol - Riluzole for patients in adult services NENC SCP - riluzole - v2.0 - approved Jan 2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 22/01/2026

Updated

27/07/2026
NENC Shared Care Protocol - Sativex for the treatment of spasticity in multiple sclerosis NENC-Shared-Care-Protocol-Sativex-for-the-treatment-of-spasticity-in-multiple-sclerosis-Updated-July 2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 23/07/2026
NENC Shared Care Protocol - Sulfasalazine for patients within adult services NENC-SCP-Sulfasalazine-for-patients-within-adult-services-v1.0-approved-Feb-2025-review-date-extended Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 13/02/2025
NENC Patient Pathway including Shared Care Agreement: Valproate Pregnancy Programme NENC Patient Valproate Pathway and SCA - v1 - approved March 2026 Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee 26/03/2026